相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy in mice
Jhansi Magisetty et al.
BLOOD (2022)
An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice
Bilgimol Chumappumkal Joseph et al.
BLOOD ADVANCES (2022)
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C
Miao Jiang et al.
BLOOD ADVANCES (2022)
Serpinpc in Persons with Severe Hemophilia (PwH): Updated Results from a Multi-Center, Multi-Part, First-in-Human Study
Trevor Baglin et al.
BLOOD (2022)
Transportation of Single-Domain Antibodies through the Blood-Brain Barrier
Eduardo Ruiz-Lopez et al.
BIOMOLECULES (2021)
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia
Xiao-Yan Zhao et al.
NATURE COMMUNICATIONS (2020)
Selective Modulation of the Protease Activated Protein C Using Exosite Inhibiting Aptamers
Nasim Shahidi Hamedani et al.
NUCLEIC ACID THERAPEUTICS (2020)
Zymogen and activated protein C have similar structural architecture
Bosko M. Stojanovski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications
Ivan Peyron et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke
Patrick Lyden et al.
ANNALS OF NEUROLOGY (2019)
PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke
Ranjeet K. Sinha et al.
BLOOD (2018)
Activated protein C, protease activated receptor 1, and neuroprotection
John H. Griffin et al.
BLOOD (2018)
Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders
Peter Szatmary et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Design and characterization of an APC-specific serpin for the treatment of hemophilia
Stephanie G. I. Polderdijk et al.
BLOOD (2017)
In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach
Nasim Shahidi Hamedani et al.
NUCLEIC ACID THERAPEUTICS (2016)
Noncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity
Fabian Stavenuiter et al.
BLOOD (2014)
Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers
Patrick Lyden et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Nanobodies as modulators of inflammation: potential applications for acute brain injury
Bjoern Rissiek et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3
Laurent Burnier et al.
BLOOD (2013)
An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway
Huang Guo et al.
JOURNAL OF NEUROSCIENCE (2013)
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
Laurent O. Mosnier et al.
BLOOD (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Protein C anticoagulant system-anti-inflammatory effects
Charles T. Esmon
SEMINARS IN IMMUNOPATHOLOGY (2012)
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation
Thomas J. Cramer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
An Exosite-Specific ssDNA Aptamer Inhibits the Anticoagulant Functions of Activated Protein C and Enhances Inhibition by Protein C Inhibitor
Jens Mueller et al.
CHEMISTRY & BIOLOGY (2009)
Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock
J. Xu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Extracellular histones are major mediators of death in sepsis
Jun Xu et al.
NATURE MEDICINE (2009)
INCREASE IN ACTIVATED PROTEIN C MEDIATES ACUTE TRAUMATIC COAGULOPATHY IN MICE
Brian B. Chesebro et al.
SHOCK (2009)
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
Meenakshisundaram Thiyagarajan et al.
JOURNAL OF NEUROSCIENCE (2008)
Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions
Laurent O. Mosnier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Exosites in the substrate specificity of blood coagulation reactions
P. E. Bock et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The functional significance of the autolysis loop in protein C and activated protein C
LK Yang et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Activated protein C variants with normal cytoprotective but reduced anticoagulant activity
LO Mosnier et al.
BLOOD (2004)
Mild bleeding diathesis in a boy with combined severe haemophilia B (C10400→T) and heterozygous factor V Leiden
F Vianello et al.
HAEMOPHILIA (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
